Offer - Urjas Oil for just ₹ 1 X
Carveday 6.25 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of High BP. Carveday 6.25 Mg Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Carveday 6.25 Mg Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Carveday 6.25 Mg Tablet as well, which are listed below. Usually, these side effects of Carveday 6.25 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Carveday 6.25 Mg Tablet's effect during pregnancy is Moderate and Safe while nursing. Warnings related to Carveday 6.25 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD) must refrain from the use of Carveday 6.25 Mg Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Carveday 6.25 Mg Tablet contraindications section.
Drug interactions for Carveday 6.25 Mg Tablet have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Carveday 6.25 Mg Tablet is considered not safe while driving, and is not addictive.
Carveday 6.25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Carveday 6.25 Mg Tablet safe for pregnant women?
Carveday can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Carveday right away. Take your doctor's advice before taking it again.
Is the use of Carveday 6.25 Mg Tablet safe during breastfeeding?
Carveday is safe for breastfeeding women.
What is the effect of Carveday 6.25 Mg Tablet on the Kidneys?
Carveday does not damage the kidneys.
What is the effect of Carveday 6.25 Mg Tablet on the Liver?
Side effects of Carveday rarely affect the liver.
What is the effect of Carveday 6.25 Mg Tablet on the Heart?
Very few cases of side effects of Carveday on the heart have been reported.
Carveday 6.25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Carveday 6.25 Mg Tablet unless your doctor advises you to do so -
Is this Carveday 6.25 Mg Tablet habit forming or addictive?
No, there is no any evidence that Carveday 6.25 Mg Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Carveday 6.25 Mg Tablet as you may feel sleepy.
Is it safe?
Yes, Carveday 6.25 Mg Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Carveday 6.25 Mg Tablet is unable to treat or cure mental disorders.
Interaction between Food and Carveday 6.25 Mg Tablet
Some foods when eaten with Carveday 6.25 Mg Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Carveday 6.25 Mg Tablet
Consumption of alcohol and Carveday 6.25 Mg Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)